alexa
Reach Us +441764910199
Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A Dbate or a Combate? | OMICS International | Abstract
ISSN: 2329-8790

Journal of Hematology & Thromboembolic Diseases
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Editorial

Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A Dbate or a Combate?

Farid Menaa*
Executive Director and Professor, Fluorotronics, Inc. CA, USA
Corresponding Author : Farid Menaa
Executive Director and Professor
Fluorotronics, Inc. CA, USA Tel: (760) 599-9496
E-mail: [email protected]
Received July 29, 2014; Accepted July 29, 2014; Published July 31, 2014
Citation: Menaa F (2014) Supplementation of Vitamin D in Patients with Sickle Cell Bone Disease: A D-bate or a Combate?. J Hematol Thrombo Dis 2:e115 doi:10.4172/2329-8790.1000e115
Copyright: © 2014 Menaa F. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Abstract

After its discovery as a genetically inherited hemoglobinopathy one hundred years ago, finding a widely available cure for sickle cell anemia (SCA, HbSS) still remains a challenge and the disease requires multi-disciplinary theranostic approaches (Menaa et al., 2013; Menaa, 2014). Indeed, more effort and resources to promptly find alternative therapeutics and/or adjuvants (e.g. nutraceutics) to HU

Top